Suppr超能文献

钾氯共转运体2(KCC2)的变化及丙泊酚诱导大鼠海马脑片长时程增强损伤中的回路活动

Changes of K+ -Cl- cotransporter 2 (KCC2) and circuit activity in propofol-induced impairment of long-term potentiation in rat hippocampal slices.

作者信息

Wang Wei, Wang Hao, Gong Neng, Xu Tian-Le

机构信息

School of Life Sciences, University of Science and Technology of China, Hefei 230027, China.

出版信息

Brain Res Bull. 2006 Oct 16;70(4-6):444-9. doi: 10.1016/j.brainresbull.2006.07.004. Epub 2006 Jul 21.

Abstract

Enhancing inhibition via gamma-aminobutyric acid type A (GABA(A)) receptors contributes to anesthetic-induced impairment of long-term potentiation (LTP) of excitatory synaptic transmission, which may account for general anesthesia-associated memory impairment (amnesia). The neuron-specific K+ -Cl- cotransporter 2 (KCC2) is necessary for fast synaptic inhibition via maintaining the low intracellular chloride concentration required for the hyperpolarizing actions of GABA via GABA(A) receptors. To explore a possible role of KCC2-dependent inhibition in anesthetic-induced impairment of LTP, we used field excitatory postsynaptic potentials (fEPSP) recording and immunoblotting to study the effect of propofol on LTP maintenance and KCC2 expression in CA1 region of rat hippocampal slices. We found that propofol (30 microM) not only impaired LTP expression but also prevented LTP-accompanied downregulation of KCC2 without affecting the basal transmission of glutamatergic synapses. Moreover, the recurrent inhibition in hippocampal slices was enhanced by propofol. These propofol-induced effects were completely abolished by picrotoxin, a specific GABA(A) receptor-chloride channel blocker. Thus, enhancement of GABAergic inhibition and suppression of neuronal excitability may account for the sustained expression of KCC2 and the impairment of LTP by propofol. Together, this study supports a novel role for KCC2 in LTP expression and gives hints to a molecular mechanism, by which anesthetics might cause impairment of LTP.

摘要

通过γ-氨基丁酸A型(GABA(A))受体增强抑制作用,会导致麻醉药引起兴奋性突触传递的长时程增强(LTP)受损,这可能是全身麻醉相关记忆障碍(失忆)的原因。神经元特异性钾氯协同转运体2(KCC2)通过维持GABA通过GABA(A)受体产生超极化作用所需的低细胞内氯离子浓度,对快速突触抑制至关重要。为了探究KCC2依赖性抑制在麻醉药诱导的LTP损伤中的可能作用,我们使用场兴奋性突触后电位(fEPSP)记录和免疫印迹法,研究丙泊酚对大鼠海马切片CA1区LTP维持和KCC2表达的影响。我们发现丙泊酚(30微摩尔)不仅损害LTP表达,还阻止了LTP伴随的KCC2下调,而不影响谷氨酸能突触的基础传递。此外,丙泊酚增强了海马切片中的反复抑制。这些丙泊酚诱导的效应被特异性GABA(A)受体-氯离子通道阻滞剂匹鲁卡品完全消除。因此,GABA能抑制的增强和神经元兴奋性的抑制可能是丙泊酚导致KCC2持续表达和LTP损伤的原因。总之,本研究支持KCC2在LTP表达中的新作用,并提示了麻醉药可能导致LTP损伤的分子机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验